Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Clinical trial NCT05691504 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05691504
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Endometrial Carcinoma Metastatic Endometrial Carcinoma Metastatic Fallopian Tube Carcinoma Metastatic Platinum-Resistant Ovarian Carcinoma Metastatic Primary Peritoneal Carcinoma Recurrent Endometrial Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Platinum-Resistant Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Start date: 2023-09-14
Primary completion: 2027-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.